Novo Nordisk A/S (CPH:NOVO.B)
265.15
+1.65 (0.63%)
At close: Apr 28, 2026
Novo Nordisk Employees
As of December 31, 2025, Novo Nordisk had 69,505 total employees, including 68,794 full-time and 711 part-time employees. The number of employees decreased by 7,844 or -10.14% compared to the previous year.
Employees
69,505
Change (1Y)
-7,844
Growth (1Y)
-10.14%
Revenue / Employee
4.47M DKK
Profits / Employee
1.48M DKK
Market Cap
1,175.73B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 69,505 | -7,844 | -10.14% |
| Dec 31, 2024 | 77,349 | 13,030 | 20.26% |
| Dec 31, 2023 | 64,319 | 9,134 | 16.55% |
| Dec 31, 2022 | 55,185 | 6,707 | 13.84% |
| Dec 31, 2021 | 48,478 | 3,155 | 6.96% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Genmab | 2,973 |
| Coloplast | 16,983 |
| ALK-Abelló | 2,613 |
| Demant | 26,704 |
| H. Lundbeck | 5,039 |
| Zealand Pharma | 501 |
| Ambu A/S | 5,200 |
| Bavarian Nordic | 1,692 |
Novo Nordisk News
- 5 hours ago - Health Canada approves first generic version of Novo Nordisk's Ozempic - Reuters
- 15 hours ago - Novo Nordisk to present new data on Wegovy®, women with obesity and next-generation weight loss treatments at European Congress on Obesity - GlobeNewsWire
- 21 hours ago - Boehringer-Zealand drug leads to 16.6% weight loss in late-stage trial - Reuters
- 1 day ago - Novo Nordisk A/S - share repurchase programme - GlobeNewsWire
- 4 days ago - Is It Too Late to Buy Novo Nordisk AS (NVO) After 6.9% Rally? GF Value Says Undervalued - GuruFocus
- 4 days ago - Lilly stock falls as Foundayo trails Novo's Wegovy in early uptake - Invezz
- 4 days ago - Battle Of The Weight-Loss Pills Continues With A Shocking Twist - Investor's Business Daily
- 4 days ago - Novo Nordisk Shares Rise After Positive Oral Semaglutide Trial In Children - Benzinga